Overview
HCA Healthcare, Inc., based in the United States, operates as a leading health care services company within the hospital industry. It manages a network of facilities that includes 182 hospitals and approximately 2,300 ambulatory sites of care like surgery centers, freestanding ERs, urgent care centers, and physician clinics across 20 states and the United Kingdom. Key projects typically focus on expanding their service capacity and improving clinical outcomes through technology-driven solutions such as patient data analytics and advanced diagnostic tools. HCA Healthcare also emphasizes the integration of electronic health records to streamline operations. Their strategic initiatives often aim to enhance patient care and expand its geographic footprint while aligning with health care regulatory requirements.
Basic Stats
The share price of HCA Healthcare, Inc. as of September 5, 2025 is $420.92 / share. This is an increase of 4.20% from the prior week. The market cap (or net worth) of HCA Healthcare, Inc. as of September 5, 2025 is $101,825.18 MM.
The Factor Analysis chart (below right) shows a view of HCA Healthcare, Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 101,825.18 MM |
| EV | 150,303.18 MM |
| Shares Out. | 241.91 MM |
| Earnings Date | |
| EPS (TTM) | 24.68 |
| Dividend Yield | 0.68 % |
| Ex-Dividend Date | 2025-09-16 |
| Borrow Rate | 0.41 |
| Short Shares Avail. | 2.10 MM |
| Short Interest | 4.12 MM |
| Short Float | 2.55 % |
| Days to Cover | 4.54 days |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | 5.83 % |
| Volatility (1 yr) | 0.28 |
| Beta | 0.46 |
| Sharpe Ratio (1 yr) | 0.06 |
| Sortino Ratio (1 yr) | 0.09 |
| PE Ratio | 17.05 |
| Price/Book | -82.25 |
| Price/TBV | -6.94 |
| Book/Market | -0.01 |
| EBIT/EV | 0.06 |
| EBIT(3yr avg)/EV | 0.06 |
| ROA | 0.10 |
| ROE | 4.46 |
| ROIC | 0.13 |
| CROIC | 0.00 |
| OCROIC | 0.25 |
| Implied Volatility | 25.55 % |
| Put/Call OI Ratio | 0.78 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for HCA Healthcare, Inc. is $401.44. The forecasts range from a low of $319.61 to a high of $466.20. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for HCA Healthcare, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2023-01-19 | Oppenheimer | Outperform | Maintains | |
| 2023-01-13 | UBS | Buy | Maintains | |
| 2022-12-16 | SVB Leerink | Outperform | Maintains | |
| 2022-12-14 | Mizuho | Buy | Maintains | |
| 2022-12-12 | Goldman Sachs | Buy | Maintains | |
| 2022-11-02 | Mizuho | Buy | Maintains | |
| 2022-10-26 | Citigroup | Buy | Maintains | |
| 2022-10-25 | Raymond James | Outperform | Maintains | |
| 2022-10-24 | Wells Fargo | Equal-Weight | Maintains | |
| 2022-10-24 | SVB Leerink | Outperform | Maintains | |
| 2022-10-24 | Stephens & Co. | Overweight | Maintains | |
| 2022-10-24 | RBC Capital | Outperform | Maintains | |
| 2022-10-24 | Oppenheimer | Outperform | Maintains | |
| 2022-09-16 | Raymond James | Outperform | Maintains | |
| 2022-08-24 | SVB Leerink | Outperform | Maintains | |
| 2022-08-02 | Mizuho | Buy | Maintains | |
| 2022-07-28 | Wells Fargo | Equal-Weight | Maintains | |
| 2022-07-26 | Raymond James | Outperform | Maintains | |
| 2022-07-25 | Truist Securities | Buy | Maintains | |
| 2022-07-25 | SVB Leerink | Outperform | Maintains | |
| 2022-07-25 | RBC Capital | Outperform | Maintains | |
| 2022-07-25 | Credit Suisse | Outperform | Maintains | |
| 2022-07-15 | SVB Leerink | Outperform | Maintains | |
| 2022-07-12 | Goldman Sachs | Buy | Maintains | |
| 2022-07-11 | Raymond James | Outperform | Maintains | |
| 2022-07-07 | Deutsche Bank | Buy | Maintains | |
| 2022-07-06 | BMO Capital | Market Perform | Underperform | Downgrade |
| 2022-07-01 | Mizuho | Buy | Maintains | |
| 2022-06-21 | RBC Capital | Outperform | Maintains | |
| 2022-06-17 | Loop Capital | Buy | Initiate | |
| 2022-05-27 | Bernstein | Market Perform | Outperform | Upgrade |
| 2022-05-03 | Mizuho | Buy | Maintains | |
| 2022-04-26 | UBS | Buy | Maintains | |
| 2022-04-26 | Raymond James | Outperform | Maintains | |
| 2022-04-25 | Wells Fargo | Equal-Weight | Maintains | |
| 2022-04-25 | Truist Securities | Buy | Maintains | |
| 2022-04-25 | SVB Leerink | Outperform | Maintains | |
| 2022-04-25 | RBC Capital | Outperform | Maintains | |
| 2022-04-25 | Credit Suisse | Outperform | Maintains | |
| 2022-04-25 | Citigroup | Buy | Maintains | |
| 2022-03-29 | Wells Fargo | Equal-Weight | Initiate | |
| 2022-01-28 | SVB Leerink | Outperform | Maintains | |
| 2022-01-28 | Cowen & Co. | Outperform | Maintains | |
| 2022-01-05 | Truist Securities | Buy | Maintains | |
| 2021-12-21 | JP Morgan | Overweight | Neutral | Downgrade |
| 2021-12-20 | Mizuho | Buy | Maintains | |
| 2021-10-26 | Raymond James | Outperform | Maintains | |
| 2021-10-25 | Stephens & Co. | Overweight | Maintains | |
| 2021-10-25 | RBC Capital | Outperform | Maintains | |
| 2021-10-25 | Oppenheimer | Outperform | Maintains | |
| 2021-10-25 | Credit Suisse | Outperform | Maintains | |
| 2021-10-25 | Citigroup | Neutral | Maintains | |
| 2021-09-27 | SVB Leerink | Outperform | Initiate | |
| 2021-09-10 | Cowen & Co. | Outperform | Initiate | |
| 2021-08-12 | Barclays | Overweight | Equal-Weight | Downgrade |
| 2021-08-06 | Goldman Sachs | Buy | Maintains | |
| 2021-07-22 | Barclays | Overweight | Maintains | |
| 2021-07-21 | Raymond James | Outperform | Maintains | |
| 2021-07-21 | Oppenheimer | Outperform | Maintains | |
| 2021-07-21 | Mizuho | Buy | Maintains | |
| 2021-07-21 | Deutsche Bank | Buy | Maintains | |
| 2021-07-21 | Credit Suisse | Outperform | Maintains | |
| 2021-07-21 | Citigroup | Neutral | Maintains | |
| 2021-07-19 | Goldman Sachs | Buy | Maintains | |
| 2021-07-09 | Seaport Global | Buy | Initiate | |
| 2021-04-26 | Citigroup | Buy | Neutral | Downgrade |
| 2021-04-26 | BMO Capital | Market Perform | Maintains | |
| 2021-04-23 | RBC Capital | Outperform | Maintains | |
| 2021-04-23 | Raymond James | Outperform | Reiterate | |
| 2021-04-23 | Mizuho | Buy | Maintains | |
| 2021-04-23 | Deutsche Bank | Buy | Maintains | |
| 2021-04-14 | Truist Securities | Buy | Maintains | |
| 2021-04-13 | Deutsche Bank | Buy | Maintains | |
| 2021-04-09 | Mizuho | Buy | Maintains | |
| 2021-02-05 | Mizuho | Buy | Maintains | |
| 2021-02-03 | Raymond James | Outperform | Maintains | |
| 2021-02-03 | Credit Suisse | Outperform | Maintains | |
| 2020-12-14 | JP Morgan | Neutral | Overweight | Upgrade |
| 2020-10-27 | Raymond James | Outperform | Maintains | |
| 2020-10-27 | Piper Sandler | Neutral | Maintains | |
| 2020-10-27 | Mizuho | Buy | Maintains | |
| 2020-10-27 | Credit Suisse | Outperform | Maintains | |
| 2020-10-09 | Credit Suisse | Outperform | Maintains | |
| 2020-09-21 | JP Morgan | Overweight | Neutral | Downgrade |
| 2020-09-16 | Truist Securities | Buy | Maintains | |
| 2020-07-23 | Raymond James | Outperform | Maintains | |
| 2020-07-23 | Piper Sandler | Neutral | Maintains | |
| 2020-07-23 | Mizuho | Buy | Maintains | |
| 2020-07-13 | BMO Capital | Outperform | Market Perform | Downgrade |
| 2020-06-11 | UBS | Buy | Maintains | |
| 2020-05-20 | Citigroup | Buy | Maintains | |
| 2020-04-27 | UBS | Buy | Maintains | |
| 2020-04-22 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2020-04-22 | Barclays | Overweight | Maintains | |
| 2020-04-20 | Raymond James | Outperform | Maintains | |
| 2020-04-13 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2020-01-29 | Stephens & Co. | Overweight | Maintains | |
| 2020-01-29 | RBC Capital | Outperform | Maintains | |
| 2020-01-29 | Credit Suisse | Outperform | Maintains | |
| 2020-01-29 | Citigroup | Buy | Maintains | |
| 2020-01-29 | Baird | Outperform | Maintains | |
| 2019-12-20 | JP Morgan | Overweight | Maintains | |
| 2019-12-06 | Bank of America | Neutral | Buy | Upgrade |
| 2019-11-20 | Bank of America | Neutral | Reiterate | |
| 2019-10-30 | UBS | Buy | Maintains | |
| 2019-10-30 | Citigroup | Buy | Maintains | |
| 2019-10-30 | Baird | Outperform | Maintains | |
| 2019-09-06 | Bank of America | Underperform | Neutral | Upgrade |
| 2019-07-10 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2019-06-24 | UBS | Buy | Maintains | |
| 2019-05-01 | UBS | Buy | Buy | Maintains |
| 2019-05-01 | Deutsche Bank | Buy | Buy | Maintains |
| 2019-04-23 | Raymond James | Market Perform | Outperform | Upgrade |
| 2019-04-17 | Barclays | Overweight | Overweight | Maintains |
| 2019-01-14 | Stephens & Co. | Overweight | Initiate | |
| 2019-01-03 | Deutsche Bank | Buy | Initiate | |
| 2018-11-16 | UBS | Buy | Initiate | |
| 2018-11-06 | Argus | Buy | Buy | Maintains |
| 2018-11-01 | Credit Suisse | Outperform | Outperform | Maintains |
| 2018-10-31 | Jefferies | Buy | Buy | Maintains |
| 2018-10-12 | Citigroup | Buy | Buy | Maintains |
| 2018-10-11 | Citigroup | Buy | Buy | Maintains |
| 2018-09-18 | Bank of America | Underperform | Underperform | Maintains |
| 2018-09-05 | Morgan Stanley | Underweight | Underweight | Maintains |
| 2018-09-05 | BMO Capital | Outperform | Outperform | Maintains |
| 2018-09-04 | Leerink Swann | Outperform | Outperform | Maintains |
| 2018-08-16 | Morgan Stanley | Underweight | Underweight | Maintains |
| 2018-08-14 | Barclays | Overweight | Initiate | |
| 2018-07-27 | Credit Suisse | Outperform | Outperform | Maintains |
| 2018-07-13 | Morgan Stanley | Underweight | Underweight | Maintains |
| 2018-02-01 | Morgan Stanley | Underweight | Underweight | Maintains |
| 2018-02-01 | BMO Capital | Outperform | Outperform | Maintains |
| 2018-01-31 | Wells Fargo | Outperform | Outperform | Maintains |
| 2018-01-31 | Leerink Swann | Outperform | Outperform | Maintains |
| 2018-01-31 | Credit Suisse | Outperform | Outperform | Maintains |
| 2018-01-04 | Bank of America | Neutral | Underperform | Downgrade |
| 2018-01-03 | PiperJaffray | Overweight | Neutral | Downgrade |
| 2017-12-20 | Morgan Stanley | Equal-Weight | Underweight | Downgrade |
| 2017-11-30 | JP Morgan | Neutral | Overweight | Upgrade |
| 2017-11-21 | William Blair | Market Perform | Initiate | |
| 2017-11-02 | Credit Suisse | Outperform | Initiate | |
| 2017-11-01 | Jefferies | Buy | Maintains | |
| 2017-10-19 | BMO Capital | Outperform | Maintains | |
| 2017-10-19 | Bank of America | Neutral | Maintains | |
| 2017-10-19 | Baird | Outperform | Maintains | |
| 2017-10-17 | BMO Capital | Outperform | Initiate | |
| 2017-10-13 | Jefferies | Buy | Maintains | |
| 2017-08-22 | Baird | Outperform | Maintains | |
| 2017-08-17 | Morgan Stanley | Equal-Weight | Maintains | |
| 2017-08-14 | Argus | Buy | Maintains | |
| 2017-07-26 | Morgan Stanley | Equal-Weight | Maintains | |
| 2017-07-26 | Citigroup | Neutral | Maintains | |
| 2017-07-26 | Bank of America | Buy | Neutral | Downgrade |
| 2017-06-28 | Argus Research | Buy | Initiate | |
| 2017-06-28 | Argus | Buy | Initiate | |
| 2017-06-07 | Morgan Stanley | Equal-Weight | Initiate | |
| 2017-06-07 | Leerink Swann | Market Perform | Outperform | Upgrade |
| 2017-04-05 | Deutsche Bank | Buy | Initiate | |
| 2017-03-27 | Mizuho | Neutral | Buy | Upgrade |
| 2017-01-04 | PiperJaffray | Overweight | Initiate | |
| 2016-11-09 | Mizuho | Buy | Neutral | Downgrade |
| 2016-11-09 | Avondale Partners | Market Outperform | Market Perform | Downgrade |
| 2016-10-13 | KeyBanc | Hold | Overweight | Upgrade |
| 2016-09-30 | Citigroup | Neutral | Maintains | |
| 2016-09-23 | Evercore ISI Group | Hold | Initiate | |
| 2016-07-29 | JP Morgan | Overweight | Neutral | Downgrade |
| 2016-07-29 | Citigroup | Neutral | Maintains | |
| 2016-06-16 | Bernstein | Market Perform | Initiate | |
| 2016-04-15 | Avondale Partners | Market Outperform | Maintains | |
| 2016-03-24 | Credit Suisse | Outperform | Maintains | |
| 2016-03-14 | JP Morgan | Neutral | Overweight | Upgrade |
| 2016-01-29 | Credit Suisse | Outperform | Maintains | |
| 2016-01-06 | Longbow Research | Outperform | Market Perform | Downgrade |
| 2016-01-06 | Barclays | Overweight | Maintains | |
| 2016-01-04 | Wells Fargo | Outperform | Market Perform | Downgrade |
| 2015-12-17 | Goldman Sachs | Buy | Neutral | Downgrade |
| 2015-12-16 | Credit Suisse | Outperform | Initiate | |
| 2015-10-28 | Leerink Swann | Outperform | Maintains | |
| 2015-10-28 | Cantor Fitzgerald | Buy | Maintains | |
| 2015-10-15 | Jefferies | Buy | Maintains | |
| 2015-10-08 | Barclays | Overweight | Maintains | |
| 2015-09-16 | JP Morgan | Neutral | Initiate | |
| 2015-07-16 | Barclays | Overweight | Maintains | |
| 2015-06-26 | Wells Fargo | Market Perform | Outperform | Upgrade |
| 2015-06-26 | Oppenheimer | Outperform | Maintains | |
| 2015-06-26 | Jefferies | Buy | Maintains | |
| 2015-06-24 | Leerink Swann | Outperform | Maintains | |
| 2015-06-10 | Wedbush | Outperform | Initiate | |
| 2015-05-06 | RBC Capital | Outperform | Maintains | |
| 2015-05-06 | Credit Suisse | Outperform | Maintains | |
| 2015-04-16 | Deutsche Bank | Buy | Maintains | |
| 2015-01-08 | Credit Suisse | Outperform | Maintains | |
| 2015-01-08 | Barclays | Overweight | Maintains | |
| 2015-01-05 | Deutsche Bank | Buy | Maintains | |
| 2014-12-18 | Sterne Agee | Buy | Initiate | |
| 2014-11-12 | Wells Fargo | Outperform | Market Perform | Downgrade |
| 2014-10-29 | Credit Suisse | Outperform | Maintains | |
| 2014-10-29 | Citigroup | Buy | Maintains | |
| 2014-10-29 | Barclays | Overweight | Maintains | |
| 2014-10-28 | Barclays | Overweight | Maintains | |
| 2014-10-02 | JP Morgan | Overweight | Maintains | |
| 2014-09-09 | Deutsche Bank | Buy | Maintains | |
| 2014-07-30 | UBS | Buy | Maintains | |
| 2014-07-30 | Credit Suisse | Outperform | Maintains | |
| 2014-07-30 | Citigroup | Buy | Maintains | |
| 2014-07-30 | Barclays | Overweight | Maintains | |
| 2014-07-17 | Raymond James | Outperform | Maintains | |
| 2014-07-17 | Deutsche Bank | Buy | Maintains | |
| 2014-06-03 | JP Morgan | Overweight | Maintains | |
| 2014-03-31 | Monness Crespi Hardt | Buy | Initiate | |
| 2014-01-15 | Raymond James | Outperform | Maintains | |
| 2013-11-13 | BMO Capital | Market Perform | Maintains | |
| 2013-10-07 | Deutsche Bank | Buy | Maintains | |
| 2013-09-18 | Mizuho | Neutral | Buy | Upgrade |
| 2013-07-11 | KeyBanc | Hold | Initiate | |
| 2013-05-13 | BMO Capital | Market Perform | Maintains | |
| 2013-05-03 | Credit Suisse | Outperform | Maintains | |
| 2013-03-25 | JP Morgan | Overweight | Maintains | |
| 2013-03-22 | Oppenheimer | Outperform | Maintains | |
| 2013-03-12 | Macquarie | Outperform | Neutral | Downgrade |
| 2013-02-11 | Morgan Stanley | Overweight | Initiate | |
| 2013-02-06 | Credit Suisse | Outperform | Maintains | |
| 2013-02-06 | BMO Capital | Market Perform | Maintains | |
| 2013-02-04 | Jefferies | Buy | Maintains | |
| 2013-01-30 | Deutsche Bank | Buy | Maintains | |
| 2013-01-25 | UBS | Buy | Maintains | |
| 2013-01-17 | Imperial Capital | Outperform | Maintains | |
| 2012-12-18 | JP Morgan | Overweight | Initiate | |
| 2012-11-07 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2012-10-11 | Barclays | Overweight | Initiate | |
| 2012-08-28 | Cantor Fitzgerald | Buy | Maintains | |
| 2012-08-20 | Imperial Capital | Outperform | Initiate | |
| 2012-08-07 | Jefferies | Buy | Maintains | |
| 2012-08-06 | Cantor Fitzgerald | Buy | Maintains | |
| 2012-05-04 | Deutsche Bank | Buy | Maintains | |
| 2012-03-23 | Cantor Fitzgerald | Buy | Initiate | |
| 2012-02-23 | Deutsche Bank | Buy | Upgrade | |
| 2023-01-30 | RBC Capital | Outperform | Maintains | |
| 2023-01-30 | Cowen & Co. | Outperform | Maintains | |
| 2023-01-30 | Citigroup | Buy | Maintains | |
| 2023-01-30 | Truist Securities | Buy | Maintains | |
| 2023-01-30 | Mizuho | Buy | Maintains | |
| 2023-01-31 | Raymond James | Outperform | Maintains | |
| 2023-02-08 | Goldman Sachs | Buy | Maintains | |
| 2023-02-22 | Stephens & Co. | Overweight | Maintains | |
| 2023-02-13 | Argus Research | Buy | Maintains | |
| 2023-02-23 | JP Morgan | Overweight | Maintains | |
| 2023-01-03 | Wells Fargo | Equal-Weight | Maintains | |
| 2023-03-13 | Stephens & Co. | Overweight | Reiterate | |
| 2023-03-16 | RBC Capital | Outperform | Reiterate | |
| 2023-04-19 | JP Morgan | Neutral | Maintains | |
| 2023-04-11 | Mizuho | Buy | Maintains | |
| 2023-04-21 | Stephens & Co. | Overweight | Reiterate | |
| 2023-04-21 | Cantor Fitzgerald | Overweight | Initiate | |
| 2023-04-24 | Credit Suisse | Outperform | Maintains | |
| 2023-04-24 | Oppenheimer | Outperform | Maintains | |
| 2023-04-24 | Citigroup | Buy | Maintains | |
| 2023-05-16 | Mizuho | Buy | Buy | Maintains |
| 2023-04-24 | Truist Securities | Buy | Maintains | |
| 2023-04-24 | Jefferies | Buy | Maintains | |
| 2023-04-24 | Deutsche Bank | Buy | Maintains | |
| 2023-04-24 | RBC Capital | Outperform | Maintains | |
| 2023-04-24 | Raymond James | Outperform | Maintains | |
| 2023-04-24 | B of A Securities | Buy | Maintains | |
| 2023-04-24 | TD Cowen | Outperform | Maintains | |
| 2023-04-24 | Loop Capital | Buy | Maintains | |
| 2023-04-25 | Wells Fargo | Equal-Weight | Maintains | |
| 2023-04-25 | Bernstein | Outperform | Maintains | |
| 2023-04-25 | Barclays | Equal-Weight | Maintains | |
| 2023-05-10 | Argus Research | Buy | Buy | Maintains |
| 2023-06-20 | Truist Securities | Buy | Buy | Maintains |
| 2023-06-28 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2023-11-10 | Stephens & Co. | Overweight | Overweight | Reiterate |
| 2023-09-13 | RBC Capital | Outperform | Outperform | Reiterate |
| 2023-10-26 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2023-10-25 | Citigroup | Buy | Buy | Maintains |
| 2023-10-25 | Stephens & Co. | Overweight | Overweight | Maintains |
| 2023-10-25 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-10-25 | Mizuho | Buy | Buy | Maintains |
| 2023-10-25 | Truist Securities | Buy | Buy | Maintains |
| 2023-07-11 | Mizuho | Buy | Buy | Maintains |
| 2023-09-14 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-12-11 | Goldman Sachs | Buy | Neutral | Downgrade |
| 2023-10-30 | Goldman Sachs | Buy | Buy | Maintains |
| 2024-01-24 | Raymond James | Outperform | Outperform | Maintains |
| 2023-07-28 | Credit Suisse | Outperform | Outperform | Maintains |
| 2023-07-28 | Oppenheimer | Outperform | Outperform | Maintains |
| 2023-10-20 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2023-10-25 | Raymond James | Outperform | Outperform | Maintains |
| 2024-01-31 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-01-31 | Truist Securities | Buy | Buy | Maintains |
| 2024-01-31 | Raymond James | Outperform | Outperform | Maintains |
| 2023-11-17 | JP Morgan | Neutral | Neutral | Maintains |
| 2024-01-19 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-01-04 | Bernstein | Outperform | Market Perform | Downgrade |
| 2024-05-30 | JP Morgan | Neutral | Neutral | Maintains |
| 2024-05-30 | Baird | Outperform | Initiate | |
| 2024-04-12 | Deutsche Bank | Buy | Buy | Maintains |
| 2024-03-05 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-04-29 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-04-29 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-01-17 | Oppenheimer | Outperform | Outperform | Reiterate |
| 2024-04-29 | Barclays | Overweight | Overweight | Maintains |
| 2024-04-30 | TD Cowen | Buy | Buy | Maintains |
| 2024-03-06 | Barclays | Overweight | Initiate | |
| 2024-03-28 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2024-04-10 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-07-10 | Barclays | Overweight | Overweight | Maintains |
| 2024-07-10 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-07-02 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-06-28 | Deutsche Bank | Buy | Buy | Maintains |
| 2024-07-09 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-07-30 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2025-01-27 | Barclays | Overweight | Overweight | Maintains |
| 2025-01-27 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2025-04-15 | Baird | Outperform | Neutral | Downgrade |
| 2025-01-27 | B of A Securities | Buy | Buy | Maintains |
| 2025-01-27 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-08-14 | UBS | Buy | Buy | Maintains |
| 2024-07-24 | Leerink Partners | Outperform | Outperform | Maintains |
| 2024-07-24 | Barclays | Overweight | Overweight | Maintains |
| 2024-07-24 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-07-24 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-07-24 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-07-24 | Truist Securities | Buy | Buy | Maintains |
| 2024-09-03 | Morgan Stanley | Equal-Weight | Initiate | |
| 2025-07-16 | Truist Securities | Buy | Buy | Maintains |
| 2024-11-22 | Raymond James | Outperform | Market Perform | Downgrade |
| 2024-11-08 | Barclays | Overweight | Overweight | Maintains |
| 2024-12-17 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-10-11 | Keybanc | Overweight | Initiate | |
| 2024-07-25 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
| 2024-10-22 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2024-08-23 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-11-06 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2024-08-19 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-08-19 | Truist Securities | Buy | Buy | Maintains |
| 2024-10-04 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2025-08-14 | Baird | Neutral | Neutral | Maintains |
| 2024-11-25 | Wells Fargo | Equal-Weight | Underweight | Downgrade |
| 2025-01-06 | Truist Securities | Buy | Buy | Maintains |
| 2024-08-20 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2025-08-14 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2024-10-28 | TD Cowen | Buy | Buy | Maintains |
| 2024-10-28 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-10-28 | Keybanc | Overweight | Overweight | Maintains |
| 2024-10-01 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2025-01-07 | Keybanc | Overweight | Overweight | Maintains |
| 2025-05-29 | Wells Fargo | Underweight | Equal-Weight | Upgrade |
| 2025-04-09 | Guggenheim | Neutral | Initiate | |
| 2025-06-02 | Barclays | Overweight | Overweight | Maintains |
| 2025-04-28 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-06-09 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-07-28 | Wolfe Research | Outperform | Peer Perform | Downgrade |
| 2025-07-16 | B of A Securities | Buy | Neutral | Downgrade |
| 2025-06-23 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-07-28 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-07-28 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-07-28 | Barclays | Overweight | Overweight | Maintains |
| 2025-08-04 | JP Morgan | Neutral | Neutral | Maintains |
| 2025-08-26 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
